D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Xerox
XRX
$337M
| $43.1M | 0.04% |
1,776,339
-423,502
| -19% | -$10.1M |
|
502
PUT
Bristol-Myers Squibb
BMY
$127B
| $43M | 0.04% |
681,500
-1,076,000
| -61% | -$66.9M |
|
|
JKS
503
JinkoSolar
JKS
$775M
| $42.9M | 0.04% |
1,029,048
-1,176,814
| -53% | -$66M |
|
504
Ovintiv
OVV
$17.5B
| $42.8M | 0.04% |
1,797,918
+1,695,934
| +1,663% | +$36.3M |
|
505
F5
FFIV
$22.1B
| $42.8M | 0.04% |
205,147
-48,583
| -19% | -$9.57M |
|
506
Sunrun
RUN
$2.37B
| $42.7M | 0.04% |
+705,977
| New | +$49.1M |
|
507
Royal Bank of Canada
RY
$291B
| $42.7M | 0.04% |
462,700
+227,348
| +97% | +$19.8M |
|
508
Fluor
FLR
$7.29B
| $42.5M | 0.04% |
1,841,409
-698,846
| -28% | -$13.6M |
|
509
PUT
Datadog
DDOG
$87.9B
| $42.5M | 0.04% |
509,700
+139,700
| +38% | +$13.5M |
|
510
CALL
Beyond Meat
BYND
$288M
| $42.3M | 0.04% |
324,900
-91,700
| -22% | -$13.5M |
|
511
Perrigo
PRGO
$1.4B
| $42.3M | 0.04% |
1,044,574
+285,384
| +38% | +$12.2M |
|
512
iHeartMedia
IHRT
$535M
| $42.2M | 0.04% |
2,327,516
+2,222,786
| +2,122% | +$33.6M |
|
513
Floor & Decor
FND
$5.81B
| $42.2M | 0.04% |
441,631
+12,391
| +3% | +$1.21M |
|
514
PUT
Charter Communications
CHTR
$14.7B
| $42M | 0.04% |
68,100
-37,900
| -36% | -$23.7M |
|
515
Pacira BioSciences
PCRX
$1.02B
| $42M | 0.04% |
598,529
-259,427
| -30% | -$18.5M |
|
|
FSR
516
DELISTED
Fisker Inc.
FSR
| $41.8M | 0.04% |
+2,428,107
| New | +$44.4M |
|
517
Community Health Systems
CYH
$385M
| $41.4M | 0.04% |
3,064,769
+346,624
| +13% | +$3.4M |
|
518
SiteOne Landscape Supply
SITE
$4.43B
| $41.4M | 0.04% |
242,539
+55,949
| +30% | +$9.29M |
|
519
PUT
Alphabet (Google) Class C
GOOG
$3.9T
| $41.4M | 0.04% |
400,000
-700,000
| -64% | -$69.4M |
|
520
CALL
TSMC
TSM
$2.09T
| $41.2M | 0.04% |
348,600
+151,500
| +77% | +$18.8M |
|
521
Citizens Financial Group
CFG
$30.4B
| $41.2M | 0.04% |
933,623
+660,348
| +242% | +$27.5M |
|
522
Liberty Media Series C
FWONK
$24.3B
| $41.2M | 0.04% |
983,773
+160,236
| +19% | +$6.77M |
|
523
Guardant Health
GH
$19.5B
| $41M | 0.04% |
268,702
+224,549
| +509% | +$33.9M |
|
524
Vontier
VNT
$4.33B
| $40.9M | 0.04% |
1,352,656
+640,752
| +90% | +$20.9M |
|
525
PUT
HubSpot
HUBS
$10.5B
| $40.9M | 0.04% |
90,000
+40,000
| +80% | +$17.6M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.